Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Clinical trial NCT02598661 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02598661
- Sponsor
- Geron Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-12
- Primary completion
- 2023-10-13
- Enrollment
- 289
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.